by Genalyte | Jul 22, 2024 | News
San Diego, CA — July 22, 2024 — Genalyte announces that it has received the first U.S. Food and Drug Administration (FDA) clearance for a Thyroid Stimulating Hormone (TSH) Immunoassay performed on a silicon chip. The FDA clearance for this assay is a significant...
by Genalyte | Apr 21, 2023 | News
San Diego, CA– Genalyte, Inc., a leading diagnostics and analytics company, announced that it has closed on the expansion of its Series C financing to include an additional $17.5 million for a total of over $67 million, led by Verily Life Sciences (an Alphabet...
by Genalyte | Nov 11, 2016 | Connective Tissue Diseases, Posters & Brochures, Scientific Publications
Presented at the 2016 ACR/ARHP Annual Meeting, November 11-15, 2016, Washington D.C.
Recent Comments